Lycia Therapeutics, Inc. — Form 4
Filed October 30, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 58/100
What the filing says
10% owner Venrock Healthcare Capital Partners III, L.P. (LYCA) bought 25K shares (~$645K) on the open market (0.4% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from October 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.